These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35076878)

  • 21. Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men.
    Mulè G; Nardi E; Costanzo M; Mogavero M; Guarino L; Viola T; Vario MG; Cacciatore V; Andronico G; Cerasola G; Cottone S
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):715-22. PubMed ID: 22494808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Office and Out-of-Office Blood Pressure Changes Over a Quarter of Century: Findings From the PAMELA Study.
    Cuspidi C; Facchetti R; Dell'Oro R; Quarti-Trevano F; Tadic M; Mancia G; Grassi G
    Hypertension; 2020 Sep; 76(3):759-765. PubMed ID: 32755470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage.
    Tsioufis C; Chatzis D; Vezali E; Dimitriadis K; Antoniadis D; Zervoudaki A; Lalos S; Kallikazaros I; Stefanadis C; Toutouzas P
    J Hum Hypertens; 2005 Mar; 19(3):211-7. PubMed ID: 15647779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risk of sustained hypertension in white-coat or masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
    Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns.
    Cuspidi C; Facchetti R; Quarti-Trevano F; Dell'Oro R; Tadic M; Gherbesi E; Grassi G; Mancia G
    J Hypertens; 2020 May; 38(5):858-863. PubMed ID: 31977573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White-Coat Hypertension: the Neglected Subgroup in Hypertension.
    Cuspidi C; Tadic M; Mancia G; Grassi G
    Korean Circ J; 2018 Jul; 48(7):552-564. PubMed ID: 29968429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining blood pressure goals: is it enough to manage total cardiovascular risk?
    Mancia G
    J Hypertens Suppl; 2009 Jul; 27(5):S3-8. PubMed ID: 19587552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni).
    Sega R; Corrao G; Bombelli M; Beltrame L; Facchetti R; Grassi G; Ferrario M; Mancia G
    Hypertension; 2002 Feb; 39(2 Pt 2):710-4. PubMed ID: 11882636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Masked hypertension and target organ damage in treated hypertensive patients.
    Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
    Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020.
    Mancia G; Facchetti R; Bombelli M; Cuspidi C; Grassi G
    Hypertension; 2021 Dec; 78(6):1677-1688. PubMed ID: 34757765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PAMELA research project: a 25-year long journey.
    Grassi G; Quarti-Trevano F; Dell'oro R; Cuspidi C; Mancia G
    Panminerva Med; 2021 Dec; 63(4):430-435. PubMed ID: 33878850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: the PAMELA study.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Hypertens; 2017 Mar; 35(3):506-512. PubMed ID: 27926692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up.
    Kanbay M; Girerd N; Machu JL; Bozec E; Duarte K; Boivin JM; Wagner S; Ferreira JP; Zannad F; Rossignol P
    Am J Hypertens; 2020 Sep; 33(9):869-878. PubMed ID: 32267470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds.
    Maloberti A; Vanoli J; Finotto A; Bombelli M; Facchetti R; Redon P; Mancia G; Grassi G
    J Clin Hypertens (Greenwich); 2023 Jan; 25(1):78-85. PubMed ID: 36573350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
    Bombelli M; Quarti-Trevano F; Tadic M; Facchetti R; Cuspidi C; Mancia G; Grassi G
    J Hypertens; 2018 Jul; 36(7):1492-1498. PubMed ID: 29543626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturnal hypertension: poor correlation with office blood pressure but strong prognostic factor for target organ damage.
    Chatzistamatiou EI; Moustakas GN; Veioglanis S; Papoutsis D; Memo G; Tsioufis C; Avgeropoulou A; Stefanadis C; Kallikazaros I
    Hellenic J Cardiol; 2012; 53(4):263-72. PubMed ID: 22796813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal dipping status and the association of morning blood pressure surge with subclinical target organ damage in untreated hypertensives.
    Gong S; Liu K; Ye R; Li J; Yang C; Chen X
    J Clin Hypertens (Greenwich); 2019 Sep; 21(9):1286-1294. PubMed ID: 31376230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pamela study: main findings and perspectives.
    Bombelli M; Toso E; Peronio M; Fodri D; Volpe M; Brambilla G; Facchetti R; Sega R; Grassi G; Mancia G
    Curr Hypertens Rep; 2013 Jun; 15(3):238-43. PubMed ID: 23609611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis.
    Mancia G; Bombelli M; Corrao G; Facchetti R; Madotto F; Giannattasio C; Trevano FQ; Grassi G; Zanchetti A; Sega R
    Hypertension; 2007 Jan; 49(1):40-7. PubMed ID: 17130308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.